Table: Garna Biosciences -Q1 group results

Carna Biosciences

10/05/2022 07:30

May 10 (Reuters)- 
             Garna Biosciences Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to   
                Mar 31, 2022        Mar 31, 2021       Dec 31, 2022  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            554 mln             231 mln             1.19      
                (+139.8 pct)         (-31.0 pct)       (-41.2 pct)   
  Operating         1 mln           loss 291 mln        loss 1.67    
  Recurring         4 mln           loss 284 mln        loss 1.69    
  Net            loss 15 mln        loss 286 mln        loss 1.74    
  EPS           loss 1.12 yen      loss 23.09 yen    loss 128.46 yen 
  Ann Div                                NIL               NIL       
  -Q2 div                                NIL               NIL       
  -Q4 div                                NIL               NIL       
  
  NOTE - Garna Biosciences Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T